Humanorganstransplantedinclude:
A. testis (deceased-donor and living-donor)
B. penis (deceased-donor)
C. uterus (deceased-donor)
D. spleen
Types of organ transplants include:
A. autograft
B. allograft & allotransplantation
C. isograft
D. xenograft & xenotransplantation
Death in the ICU will usually occur in the following ways:
A. Patients are receiving full treatment, suffer a cardiac arrest, and an attempt at CPR is made but is unsuccessful
B. Patients are receiving full treatment, suffer a cardiac arrest, and no attempt at CPR is made (DNR orders in place)
C. Some or all of full treatment is withheld or withdrawn, the patient suffers a cardiac arrest, and no attempt at CPR is initiated
Death is determined based on neurologic criteria (neurological determination of death/brain death)
Confirmatory imaging studies for brain death include:
A. Radionuclide angiography and brain perfusion nuclear medicine imaging (Tc-99m HMPAO or Tc-99m ECD)
B. Magnetic resonance angiography
CT angiography and four vessel cerebral angiography
D. Transcranial Doppler ultrasound
Pre-mortem donor interventions may include:
A. Blood testing for donor eligibility (tissue typing, cross match, virology screen and organ function testing)
B. Staged preparation for in situ preservation or extracorporeal oxygenated perfusion, which may include sterile preparation and draping of the surgical field, isolation of femoral vessels by surgical cutdown and cannulation of vessels
C. Pharmacological interventions: administration of anticoagulants (e.g., heparin), arterial vasodilators (e.g., phentolamine) and thrombolytics. To be effective, intact circulation (prior to death) is required for systemic distribution, although some centers administer them after death in the preservation solution.
D. preprationof money to pay donors' family
微信支付 
支付宝支付